<DOC>
	<DOCNO>NCT00649610</DOCNO>
	<brief_summary>The pain relief , safety , tolerability valdecoxib 40 mg daily compare diclofenac 75 mg twice daily acute low back pain study . The effect valdecoxib patient 's level disability quality life also study .</brief_summary>
	<brief_title>Randomized , Double Blind , Multicenter Study Safety Efficacy Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily Acute Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Valdecoxib</mesh_term>
	<criteria>Acute low back pain , define either class 1a class 2a accord Quebec Task Force Classification categorize moderatesevere Pain Intensity Categorical Scale Visual analogue score ( VAS ) great equal 50 mm Acute low back pain start least 72 hour prior inclusion trial 6 week last episode acute low back pain History least 1 report episode acute low back pain last 5 year History inflammatory arthritis , chronic pain , metastasis , Paget 's disease , diseases know cause pain Moderate severe scoliosis Back pain due major trauma visceral disorder Unwilling refrain commence concomitant physiotherapy Active suspect esophageal , gastric pyloric channel , duodenal ulceration bleed within 30 day prior first dose study medication Any known laboratory abnormality , opinion investigator , would contraindicate study participation Subject pregnant lactating woman , woman childbearing potential use acceptable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>acute low back pain</keyword>
</DOC>